COMMUNIQUÉS West-GlobeNewswire

Sienna Biopharmaceuticals Announces Pivotal Trials with SNA-001 in Acne Did Not Meet Primary and Secondary Endpoints
30/07/2018
-- Results from independent pivotal trials with SNA-001 for the reduction of unwanted light-pigmented hair expected beginning in the fourth quarter of 2018 -- Sienna continues to advance robust multi-asset pipeline, [...]
Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides a Business Update
30/07/2018
XERMELO ® (telotristat ethyl) Quarterly U.S. Net Sales of $6.0 Million, Up 65% from Prior Year Quarter and 11% Quarter-Over-Quarter Filings for Regulatory Approval of Sotagliflozin in Type 1 Diabetes Accepted THE [...]
CLS Exhibits Thermal Therapy Laser Ablation System at AdMeTech Annual Conference
30/07/2018
Unique Non-Cooled Fiber Technology Optimizes Heat Distribution, Eliminates External Cooling, Reduces Procedure Times FRAMINGHAM, Mass., July 30, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc . ( [...]
Emerald Health Therapeutics’ Cannabis Joint Venture Pure Sunfarms Receives Sales License from Health Canada for 1.1 Million Square Foot Greenhouse
30/07/2018
Pure Sunfarms’ Delta 3 greenhouse facility becomes one of the largest Canadian cannabis growing operations licensed to sell product, with significant production and sales ramp expected through 2018 and beyond VANCOUVER [...]
RedHill Biopharma Announces Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease
30/07/2018
Primary endpoint successfully achieved - superior remission rate at week 26 in patients treated with RHB-104 (p= 0.013) Key secondary endpoints also met, demonstrating consistent benefit to Crohn’s disease patients [...]
resTORbio to Present at the Canaccord Genuity 38th Annual Growth Conference
30/07/2018
BOSTON, July 30, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
Xeris Pharmaceuticals Announces New Board Members and New Executive to Management Team
30/07/2018
Appointments reflect transition to publicly-listed company status CHICAGO, July 30, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a specialty pharmaceutical company leveraging its novel technology [...]
Genetic Technologies Announces Appointment of Swisstec as Non-Exclusive Asian Distributor
30/07/2018
MELBOURNE, Australia, July 30, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“ Company ”, “ GTG ”), a diversified molecular diagnostics company embracing blockchain technologies across [...]
Opthea Doses First Patient in Phase 2a Trial for OPT-302 in Diabetic Macular Edema
30/07/2018
MELBOURNE, Australia, July 30, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a late stage biopharmaceutical company developing novel biologic therapies to treat back-of-the eye diseases, has successfully dosed the [...]
The Ensign Group Schedules Second Quarter 2018 Earnings Call for Friday, August 3, 2018
30/07/2018
MISSION VIEJO, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, assisted living, home health [...]
Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics
30/07/2018
Sunnyvale, July 30, 2018 (GLOBE NEWSWIRE) -- July 30, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, signs allergy testing contracts with a consortium of [...]
Kymab Announces Promising Results from Initial Clinical Study of New Antibody KY1005 for Treatment of Autoimmune Diseases
30/07/2018
Kymab Announces Promising Results from Initial Clinical Study of N ew Antibody KY1005 for Treatment of Autoimmune Diseases Top-line Phase I data demonstrated favorable safety, pharmacokinetics and pharmacodynamic [...]
New STING study opens up multi-billion dollar cancer immunotherapy market for LIDDS unique NanoZolid® technology
30/07/2018
The preclinical study proves that a single intratumoral injection of a NanoZolid® formulated STING-agonist has equal or better efficacy compared to multiple injections of a standard STING-agonist treatment, thereby [...]
Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate
30/07/2018
Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate Tokyo, Berlin, Basking Ridge, NJ – (July 30, 2018) – Daiichi Sankyo Company, Limited (hereafter, Daiichi [...]
Herantis Pharma Oyj: Manager's Transactions - Pekka Simula
30/07/2018
Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 30 July 2018 at 9:30 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Changes to Biohit Oyj’s management
30/07/2018
Adjunct professor (molecular mircobiology) and computer science engineer Minna Mäki (b. 1969) has been appointed R&D and production director and as a member of the Management Team of Biohit Oyj starting July 30th [...]
CrownBio étend de nouveaux modèles humanisés destinés au développement d’immunothérapies ciblées à son centre de recherche de San Diego, en Californie
30/07/2018
Le programme d‘expansion des modèles humanisés commencera par les modèles PD-1, CTLA-4 et CD137 SAN DIEGO, 30 juill. 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , société internationale de services de découverte et de [...]
Shire plc : Miscellaneous
30/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 30 July 2018 Shire [...]
MediciNova Announces Full Enrollment in ALS Biomarker Clinical Trial
30/07/2018
LA JOLLA, Calif., July 29, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]

Pages